These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3254072)

  • 1. Mucosal priming alters pathogenesis of Rift Valley fever.
    Anderson AO; Snyder LF; Pitt ML; Wood OL
    Adv Exp Med Biol; 1988; 237():717-23. PubMed ID: 3254072
    [No Abstract]   [Full Text] [Related]  

  • 2. Modifying the NSs gene to improve live-attenuated vaccine for Rift Valley fever.
    Lihoradova O; Ikegami T
    Expert Rev Vaccines; 2012 Nov; 11(11):1283-5. PubMed ID: 23249225
    [No Abstract]   [Full Text] [Related]  

  • 3. MBT/Pas mouse: a relevant model for the evaluation of Rift Valley fever vaccines.
    Ayari-Fakhfakh E; do Valle TZ; Guillemot L; Panthier JJ; Bouloy M; Ghram A; Albina E; Cêtre-Sossah C
    J Gen Virol; 2012 Jul; 93(Pt 7):1456-1464. PubMed ID: 22513390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
    Morrill JC; Peters CJ
    J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rift valley fever vaccines.
    Ikegami T; Makino S
    Vaccine; 2009 Nov; 27 Suppl 4():D69-72. PubMed ID: 19837291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct Pathological Changes in Preweaning Mice Infected with Live-Attenuated Rift Valley Fever Virus Strains.
    Alkan C; Jurado-Cobena E; Ikegami T
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
    Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
    Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.
    Miller MM; Bennett KE; Drolet BS; Lindsay R; Mecham JO; Reeves WK; Weingartl HM; Wilson WC
    Clin Vaccine Immunol; 2015 Aug; 22(8):930-7. PubMed ID: 26041042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs.
    Lagerqvist N; Näslund J; Lundkvist A; Bouloy M; Ahlm C; Bucht G
    Virol J; 2009 Jan; 6():6. PubMed ID: 19149901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
    Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
    von Teichman B; Engelbrecht A; Zulu G; Dungu B; Pardini A; Bouloy M
    Vaccine; 2011 Aug; 29(34):5771-7. PubMed ID: 21664400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rift Valley fever.
    Shimshony A; Barzilai R
    Adv Vet Sci Comp Med; 1983; 27():347-425. PubMed ID: 6359835
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine.
    Morrill JC; Peters CJ
    J Infect Dis; 2011 Aug; 204(4):617-25. PubMed ID: 21791664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infectious, immunogenic, and protective characteristics of the Rift Valley fever virus depending on the passage level and storage conditions].
    Zakutskiy NI; Balysheva VI; Khukhorova I Ju ; Yurkov SG
    Vopr Virusol; 2015; 60(2):41-3. PubMed ID: 26182657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
    Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.
    Morrill JC; Laughlin RC; Lokugamage N; Pugh R; Sbrana E; Weise WJ; Adams LG; Makino S; Peters CJ
    Vaccine; 2013 Jan; 31(3):559-65. PubMed ID: 23153443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H; Lorenzo G; Rodriguez F; Brun A
    Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of veterinary vaccines for preventing and combatting Rift Valley fever: memorandum of a WHO/FAO meeting].
    Bull World Health Organ; 1983; 61(3):447-55. PubMed ID: 6603918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.